Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Decoding the pharmacological goldmine in tick saliva.

A new study led by Radcliffe Department of Medicine, Professor Shoumo Bhattacharya, has decoded the structure of unique proteins found in tick saliva and created new ones not found in nature, paving the way for a new generation of ‘Swiss-army knife’ anti-inflammatory drugs, with customised extensions to block different inflammatory pathways.  

Previous research by Professor Shoumo Bhattacharya underlines that tick saliva can be a pharmacological gold mine, potentially yielding many new drugs which could treat disorders ranging from cardiovascular diseases and stroke to arthritis. This previous work identified a group of tick saliva proteins called evasins, which bind to and neutralise chemokines, a group of chemicals key to causing inflammation in the body.

Now the researchers have worked out the structural trick that enables tick evasins to block a complex pathway that has multiple routes to the same response. What’s more, they can now manipulate this structure to make new, custom-made proteins based on tick evasins.

Read more (Radcliffe Department of Medicine website)

Similar stories

Unlocking the Secrets of cAMP Signalling in the Heart: A Pathway to Targeted Therapeutics

A new Zaccolo group study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. They have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Professor Barbara Casadei awarded 2022 Nylin Medal

The Swedish Society of Medicine has awarded the 2022 Nylin Medal to Professor Barbara Casadei, part of the Oxford BHF CRE leadership team.

Joaquim Vieira recognised in national image competition

DPAG BHF Intermediate Research Fellow Dr Joaquim Vieira has been shortlisted for the British Heart Foundation’s annual ‘Reflections of Research’ image competition.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.